Article
Sequence and structure based models of HIV-1 protease and reverse transcriptase drug resistance.
BMC genomics - 1 Jan 2013
Masso Majid, Vaisman Iosif I
Abstract excerpt
BACKGROUND: Successful management of chronic human immunodeficiency virus type 1 (HIV-1) infection with a cocktail of antiretroviral medications can be negatively affected by the presence of drug resistant mutations in the viral targets. These targets include the HIV-1 protease (PR) and reverse transcriptase (RT) proteins, for which a number of inhibitors are available on the market and routinely prescribed....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
